Baxalta's headquarters was located in Bannockburn, Illinois. While it maintained its headquarters in Bannockburn during its independent operation, Baxalta no longer exists as a standalone entity with a separate headquarters.
Historic Headquarters Location
During its period as an independent biopharmaceutical company, Baxalta Incorporated established its primary operational base and headquarters in Bannockburn, Illinois. This location served as the central point for its global operations, research and development, and administrative functions before its acquisition.
Here's a quick overview of its former headquarters:
| Attribute | Detail |
|---|---|
| Company Name (Former) | Baxalta Incorporated |
| Former HQ Location | Bannockburn, Illinois, USA |
| Industry Sector | Biopharmaceutical |
| Operational Status | Acquired; Integrated |
Baxalta's Evolution and Acquisition
Baxalta was originally spun off from Baxter International in July 2015, becoming an independent global biopharmaceutical company. Its focus was on developing and marketing treatments for rare diseases, hemophilia, and other chronic conditions.
However, Baxalta's independence was short-lived. In June 2016, it was acquired by Shire plc, a prominent global biopharmaceutical company based in Dublin, Ireland, in a deal valued at approximately $32 billion. Following this acquisition, Baxalta's operations and product portfolio were integrated into Shire's existing structure.
Further consolidating the biopharmaceutical landscape, Shire plc itself was subsequently acquired by Takeda Pharmaceutical Company Limited, a major Japanese multinational pharmaceutical company, in January 2019. This acquisition, valued at around $62 billion, created one of the world's largest pharmaceutical companies.
Key milestones in Baxalta's journey include:
- 2015: Spun off from Baxter International to become an independent publicly traded company.
- 2016: Acquired by Shire plc, integrating its assets and operations under the Shire brand.
- 2019: Shire, including the former Baxalta assets, was acquired by Takeda Pharmaceutical Company Limited.
Current Status
As a result of these strategic acquisitions, Baxalta Incorporated no longer functions as an independent company with a distinct headquarters in Bannockburn or anywhere else. Its former operations, therapies, and intellectual property are now fully integrated components of Takeda Pharmaceutical Company Limited's global portfolio. Therefore, any inquiries regarding its current operational base would fall under Takeda's corporate structure and headquarters.
